annual EBITDA:
$1.65B+$267.60M(+19.30%)Summary
- As of today (June 22, 2025), UTHR annual EBITDA is $1.65 billion, with the most recent change of +$267.60 million (+19.30%) on December 31, 2024.
- During the last 3 years, UTHR annual EBITDA has risen by +$992.00 million (+149.76%).
- UTHR annual EBITDA is now at all-time high.
Performance
UTHR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$449.40M+$25.30M(+5.97%)Summary
- As of today (June 22, 2025), UTHR quarterly EBITDA is $449.40 million, with the most recent change of +$25.30 million (+5.97%) on March 31, 2025.
- Over the past year, UTHR quarterly EBITDA has increased by +$22.50 million (+5.27%).
- UTHR quarterly EBITDA is now -39.75% below its all-time high of $745.90 million, reached on September 30, 2015.
Performance
UTHR quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.68B+$22.50M(+1.36%)Summary
- As of today (June 22, 2025), UTHR TTM EBITDA is $1.68 billion, with the most recent change of +$22.50 million (+1.36%) on March 31, 2025.
- Over the past year, UTHR TTM EBITDA has increased by +$182.20 million (+12.19%).
- UTHR TTM EBITDA is now at all-time high.
Performance
UTHR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
UTHR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.3% | +5.3% | +12.2% |
| 3 y3 years | +149.8% | +37.9% | +78.6% |
| 5 y5 years | +2308.8% | +133.8% | +124.4% |
UTHR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +149.8% | at high | +165.1% | at high | +91.7% |
| 5 y | 5-year | at high | +2308.8% | at high | +806.0% | at high | +194.3% |
| alltime | all time | at high | +2127.9% | -39.8% | +171.3% | at high | +1291.0% |
UTHR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $449.40M(+6.0%) | $1.68B(+1.4%) |
| Dec 2024 | $1.65B(+19.3%) | $424.10M(+1.5%) | $1.65B(+6.4%) |
| Sep 2024 | - | $417.80M(+8.4%) | $1.55B(+2.4%) |
| Jun 2024 | - | $385.60M(-9.7%) | $1.52B(+1.5%) |
| Mar 2024 | - | $426.90M(+31.7%) | $1.49B(+7.8%) |
| Dec 2023 | $1.39B(+34.1%) | $324.20M(-14.8%) | $1.39B(+9.5%) |
| Sep 2023 | - | $380.70M(+4.9%) | $1.27B(+3.8%) |
| Jun 2023 | - | $362.90M(+13.8%) | $1.22B(+18.8%) |
| Mar 2023 | - | $319.00M(+56.1%) | $1.03B(-0.7%) |
| Dec 2022 | $1.03B(+56.1%) | $204.30M(-38.9%) | $1.03B(+4.7%) |
| Sep 2022 | - | $334.60M(+97.4%) | $987.80M(+12.9%) |
| Jun 2022 | - | $169.50M(-48.0%) | $874.60M(-6.8%) |
| Mar 2022 | - | $325.90M(+106.5%) | $938.70M(+41.7%) |
| Dec 2021 | $662.40M(-7.0%) | $157.80M(-28.7%) | $662.40M(+4.0%) |
| Sep 2021 | - | $221.40M(-5.2%) | $636.90M(-2.2%) |
| Jun 2021 | - | $233.60M(+371.0%) | $651.20M(+14.3%) |
| Mar 2021 | - | $49.60M(-62.5%) | $569.70M(-20.0%) |
| Dec 2020 | $712.30M(-1051.0%) | $132.30M(-43.9%) | $712.30M(+6.2%) |
| Sep 2020 | - | $235.70M(+55.0%) | $670.80M(+7.1%) |
| Jun 2020 | - | $152.10M(-20.9%) | $626.40M(-16.2%) |
| Mar 2020 | - | $192.20M(+111.7%) | $747.30M(-1097.7%) |
| Dec 2019 | -$74.90M(-109.3%) | $90.80M(-52.5%) | -$74.90M(+26.9%) |
| Sep 2019 | - | $191.30M(-29.9%) | -$59.00M(-39.0%) |
| Jun 2019 | - | $273.00M(-143.3%) | -$96.70M(-31.3%) |
| Mar 2019 | - | -$630.00M(-690.4%) | -$140.80M(-117.4%) |
| Dec 2018 | $808.70M(-0.1%) | $106.70M(-30.5%) | $808.70M(-5.3%) |
| Sep 2018 | - | $153.60M(-32.9%) | $854.20M(-17.3%) |
| Jun 2018 | - | $228.90M(-28.4%) | $1.03B(+20.5%) |
| Mar 2018 | - | $319.50M(+109.9%) | $856.70M(+5.8%) |
| Dec 2017 | $809.50M(-26.1%) | $152.20M(-54.1%) | $809.50M(-3.5%) |
| Sep 2017 | - | $331.70M(+522.3%) | $838.80M(+11.1%) |
| Jun 2017 | - | $53.30M(-80.4%) | $754.90M(-24.2%) |
| Mar 2017 | - | $272.30M(+50.0%) | $995.80M(-9.1%) |
| Dec 2016 | $1.10B(+1.3%) | $181.50M(-26.8%) | $1.10B(+1.6%) |
| Sep 2016 | - | $247.80M(-15.8%) | $1.08B(-31.6%) |
| Jun 2016 | - | $294.20M(-21.0%) | $1.58B(+7.9%) |
| Mar 2016 | - | $372.20M(+126.4%) | $1.46B(+35.0%) |
| Dec 2015 | $1.08B(+88.2%) | $164.40M(-78.0%) | $1.08B(-2.1%) |
| Sep 2015 | - | $745.90M(+318.8%) | $1.10B(+228.9%) |
| Jun 2015 | - | $178.10M(-2882.8%) | $335.89M(-2.1%) |
| Mar 2015 | - | -$6.40M(-103.4%) | $343.21M(-40.3%) |
| Dec 2014 | $575.00M(+75.2%) | $187.21M(-913.3%) | $575.00M(+56.0%) |
| Sep 2014 | - | -$23.02M(-112.4%) | $368.48M(-27.0%) |
| Jun 2014 | - | $185.42M(-17.7%) | $504.88M(+12.2%) |
| Mar 2014 | - | $225.39M(-1266.9%) | $450.18M(+37.2%) |
| Dec 2013 | $328.22M(-32.2%) | -$19.32M(-117.0%) | $328.22M(-32.2%) |
| Sep 2013 | - | $113.38M(-13.3%) | $484.27M(-1.3%) |
| Jun 2013 | - | $130.72M(+26.4%) | $490.68M(+3.6%) |
| Mar 2013 | - | $103.44M(-24.4%) | $473.42M(-2.3%) |
| Dec 2012 | $484.45M(+42.1%) | $136.73M(+14.1%) | $484.45M(+16.0%) |
| Sep 2012 | - | $119.79M(+5.6%) | $417.72M(+2.7%) |
| Jun 2012 | - | $113.46M(-0.9%) | $406.59M(-1.6%) |
| Mar 2012 | - | $114.47M(+63.5%) | $413.01M(+20.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $341.02M(+76.9%) | $70.00M(-35.6%) | $341.83M(+17.1%) |
| Sep 2011 | - | $108.66M(-9.4%) | $291.81M(+16.1%) |
| Jun 2011 | - | $119.88M(+177.0%) | $251.33M(+26.9%) |
| Mar 2011 | - | $43.28M(+116.6%) | $198.10M(+2.8%) |
| Dec 2010 | $192.78M(+348.0%) | $19.98M(-70.7%) | $192.76M(+9.3%) |
| Sep 2010 | - | $68.18M(+2.3%) | $176.42M(+43.3%) |
| Jun 2010 | - | $66.65M(+75.7%) | $123.12M(+117.6%) |
| Mar 2010 | - | $37.94M(+940.3%) | $56.58M(+31.5%) |
| Dec 2009 | $43.04M(-163.5%) | $3.65M(-75.5%) | $43.03M(-146.8%) |
| Sep 2009 | - | $14.88M(>+9900.0%) | -$91.91M(+8.2%) |
| Jun 2009 | - | $108.00K(-99.6%) | -$84.91M(+28.6%) |
| Mar 2009 | - | $24.40M(-118.6%) | -$66.03M(-11.3%) |
| Dec 2008 | -$67.75M(-405.4%) | -$131.30M(-700.0%) | -$74.44M(-214.6%) |
| Sep 2008 | - | $21.88M(+15.2%) | $64.98M(+13.5%) |
| Jun 2008 | - | $18.99M(+18.8%) | $57.26M(+22.9%) |
| Mar 2008 | - | $15.98M(+96.7%) | $46.57M(+100.3%) |
| Dec 2007 | $22.18M(-27.1%) | $8.13M(-42.6%) | $23.25M(+24.4%) |
| Sep 2007 | - | $14.16M(+70.5%) | $18.70M(+14.2%) |
| Jun 2007 | - | $8.30M(-213.2%) | $16.38M(-18.5%) |
| Mar 2007 | - | -$7.33M(-305.3%) | $20.09M(-34.0%) |
| Dec 2006 | $30.45M(-32.8%) | $3.57M(-69.8%) | $30.45M(-19.6%) |
| Sep 2006 | - | $11.83M(-1.5%) | $37.85M(-8.0%) |
| Jun 2006 | - | $12.02M(+297.8%) | $41.14M(+0.6%) |
| Mar 2006 | - | $3.02M(-72.5%) | $40.90M(-9.7%) |
| Dec 2005 | $45.31M(+192.6%) | $10.97M(-27.5%) | $45.31M(+9.8%) |
| Sep 2005 | - | $15.13M(+28.4%) | $41.26M(+27.3%) |
| Jun 2005 | - | $11.78M(+58.5%) | $32.41M(+31.2%) |
| Mar 2005 | - | $7.43M(+7.2%) | $24.70M(+59.5%) |
| Dec 2004 | $15.48M(-268.3%) | $6.93M(+10.4%) | $15.49M(+172.9%) |
| Sep 2004 | - | $6.27M(+54.1%) | $5.67M(-419.8%) |
| Jun 2004 | - | $4.07M(-327.6%) | -$1.77M(-78.0%) |
| Mar 2004 | - | -$1.79M(-37.9%) | -$8.08M(-12.2%) |
| Dec 2003 | -$9.20M(-38.1%) | -$2.88M(+145.6%) | -$9.20M(+2.9%) |
| Sep 2003 | - | -$1.17M(-47.4%) | -$8.94M(-34.9%) |
| Jun 2003 | - | -$2.23M(-23.5%) | -$13.74M(+16.1%) |
| Mar 2003 | - | -$2.91M(+11.1%) | -$11.83M(-20.4%) |
| Dec 2002 | -$14.87M(-65.8%) | -$2.62M(-56.1%) | -$14.87M(-27.0%) |
| Sep 2002 | - | -$5.97M(+1736.9%) | -$20.36M(-20.0%) |
| Jun 2002 | - | -$325.00K(-94.5%) | -$25.45M(-31.9%) |
| Mar 2002 | - | -$5.95M(-26.6%) | -$37.34M(-12.4%) |
| Dec 2001 | -$43.42M(-46.8%) | -$8.11M(-26.6%) | -$42.62M(-35.0%) |
| Sep 2001 | - | -$11.06M(-9.5%) | -$65.58M(+1.0%) |
| Jun 2001 | - | -$12.22M(+8.8%) | -$64.93M(-22.0%) |
| Mar 2001 | - | -$11.23M(-63.9%) | -$83.20M(+2.0%) |
| Dec 2000 | -$81.58M(+122.5%) | -$31.07M(+198.5%) | -$81.58M(+32.9%) |
| Sep 2000 | - | -$10.41M(-65.8%) | -$61.37M(+6.1%) |
| Jun 2000 | - | -$30.48M(+217.1%) | -$57.86M(+72.3%) |
| Mar 2000 | - | -$9.61M(-11.5%) | -$33.58M(-7.4%) |
| Dec 1999 | -$36.66M(+174.7%) | -$10.86M(+57.4%) | -$36.26M(+42.8%) |
| Sep 1999 | - | -$6.90M(+11.3%) | -$25.40M(+37.3%) |
| Jun 1999 | - | -$6.20M(-49.6%) | -$18.50M(+50.4%) |
| Mar 1999 | - | -$12.30M | -$12.30M |
| Dec 1998 | -$13.35M | - | - |
FAQ
- What is United Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for United Therapeutics?
- What is United Therapeutics annual EBITDA year-on-year change?
- What is United Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for United Therapeutics?
- What is United Therapeutics quarterly EBITDA year-on-year change?
- What is United Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for United Therapeutics?
- What is United Therapeutics TTM EBITDA year-on-year change?
What is United Therapeutics annual EBITDA?
The current annual EBITDA of UTHR is $1.65B
What is the all time high annual EBITDA for United Therapeutics?
United Therapeutics all-time high annual EBITDA is $1.65B
What is United Therapeutics annual EBITDA year-on-year change?
Over the past year, UTHR annual EBITDA has changed by +$267.60M (+19.30%)
What is United Therapeutics quarterly EBITDA?
The current quarterly EBITDA of UTHR is $449.40M
What is the all time high quarterly EBITDA for United Therapeutics?
United Therapeutics all-time high quarterly EBITDA is $745.90M
What is United Therapeutics quarterly EBITDA year-on-year change?
Over the past year, UTHR quarterly EBITDA has changed by +$22.50M (+5.27%)
What is United Therapeutics TTM EBITDA?
The current TTM EBITDA of UTHR is $1.68B
What is the all time high TTM EBITDA for United Therapeutics?
United Therapeutics all-time high TTM EBITDA is $1.68B
What is United Therapeutics TTM EBITDA year-on-year change?
Over the past year, UTHR TTM EBITDA has changed by +$182.20M (+12.19%)